About ProChon Biotech
ProChon Biotech is a Healthcare company based in Rehovot (Israel) founded in 1996, and was acquired by Histogenics in May 2011. Regenerative biology products for cartilage lesions are developed and commercialized. The company was acqui-hired. Its focus areas include Life Sciences, Cell Therapy, Diversified and Orthopedics.
Company details
ProChon Biotech develops and commercializes regenerative biology-based products for acute and chronic articular cartilage focal lesions. The company focuses on modulating the fibroblast growth factor system to enable it to create solutions for tissue regeneration. It offers orthobiologic therapeutic solutions, including BioCart Autologous Cartilage Regeneration system, a solution for the restoration of articular cartilage lesions that results in the regeneration of hyaline-like tissue. It was acquired by Histogenics in May, 2011.
- Headquarters Rehovot, Israel
- Stage Acquired
- SectorsHealthcare
- Website prochon.com
- Social LinkedIn
- Acquired by Histogenics (May 2011)
- Latest Funding Round$3.95M (USD), Debt – Convertible
Jan 2010
- Investors
- Acquired byHistogenics
(May 2011)
Funding Insights of ProChon Biotech
- Total Rounds 1
- Last Round Debt – Convertible — $3.95M
- First Round $3.95M
(Jan 2010)
All 1 funding rounds of ProChon Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2010 | $3.95M | Debt – Convertible | – | – | – |
1 investors in total: 1 institutional.
Investors in ProChon Biotech
ProChon Biotech has secured backing from 1 investor. Prominent investors backing the company include Histogenics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Restorative cell therapies for orthopedic diseases are developed. | 2000 | histogenics.com | Waltham, United States |
Investor details for ProChon Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ProChon Biotech
3 dated milestones of ProChon Biotech across 15 years, from founding to its latest funding, stage changes and deals.
- Founded ProChon Biotech is founded.
- Funding First funding round of $4.0M.
- Exit Acquired by Histogenics.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ProChon Biotech
ProChon Biotech was founded in 1996 and raised its 1st funding round 14 years after it was founded.
ProChon Biotech is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
ProChon Biotech develops and commercializes regenerative biology-based products for acute and chronic articular cartilage focal lesions. The company focuses on modulating the fibroblast growth factor system to enable it to create solutions for tissue regeneration. It offers orthobiologic therapeutic solutions, including BioCart Autologous Cartilage Regeneration system, a solution for the restoration of articular cartilage lesions that results in the regeneration of hyaline-like tissue. It was acquired by Histogenics in May, 2011.
ProChon Biotech has 1 investor. Key investors include Histogenics.
Yes. ProChon Biotech was acquired by Histogenics in May 2011.